Alle Storys
Folgen
Keine Story von Quintiles Transnational Corp. mehr verpassen.

Quintiles Transnational Corp.

Yoh Narimatsu Appointed President and Chief Executive Officer of Quintiles Japan

Research Triangle Park, North Carolina (ots/PRNewswire)

Quintiles Transnational Corp. today announced the appointment of
Yoh Narimatsu as President and Chief Executive Officer of Quintiles
Transnational Japan K.K. (Quintiles Japan) effective April 1.
Narimatsu, who has more than 30 years of international business
experience, will lead all operations of Quintiles Japan. Quintiles
Japan is a leading provider of development, commercial and financial
solutions to pharma and biotech companies operating in Japan, the
world's second-largest pharmaceutical market.
Prior to joining Quintiles, Narimatsu was President and Country
General Manager of Agilent Technologies Japan, Ltd., a global
technology leader in communications, electronics, life sciences and
chemical analysis.
Narimatsu, 57, will report to Quintiles Transnational Chairman and
CEO Dennis Gillings, CBE. He succeeds Mikihiko Obayashi, Ph.D., as
President of Quintiles Japan. Obayashi will remain Vice Chairman of
Quintiles Japan, a position he has held since 2004.
Narimatsu also will be a member of the Quintiles Japan Board,
which provides oversight and governance of Quintiles Japan operations
from national and global perspectives; Gillings will continue to
serve as Chairman of that Board.
"Narimatsu-san brings to Quintiles Japan extensive management
experience and demonstrated success in managing the Japanese
operations of a multi-faceted global organization," Gillings said.
"The Japanese pharmaceutical market is dynamic, and with this
appointment I believe we've significantly enhanced our ability to
help our pharmaceutical and biotech customers succeed in Japan and
globally."
Narimatsu joined Agilent Technologies Japan in 1999 as President
and Country General Manager. Prior to that, he was General Manager of
the Kobe Instrument Division of Hewlett-Packard Japan. He began his
career at Hewlett-Packard in 1971 as a research and development
engineer and served in increasingly responsible positions in the
United States and Japan during his 28-year career with the company.
Narimatsu received a bachelor's degree in electrical engineering
from Kyoto University in Kyoto, Japan, in 1971; a master's degree in
electrical engineering from Stanford University in 1976; and a
master's degree in business administration in 1995, also from
Stanford.
Quintiles is the global leader in pharmaceutical services. We
improve healthcare worldwide by providing innovative, quality
professional expertise, market intelligence and partnering solutions
to meet the dynamic needs of the pharmaceutical, biotechnology and
healthcare industries. Quintiles has 16,000 specialized employees and
offices in 50 countries. For more information visit the company's Web
site at http://www.quintiles.com.
Web site: http://www.quintiles.com

Contact:

Pat Grebe, Media Relations, +1-919-998-2091,
media.info@quintiles.com, or Greg Connors, Investor Relations,
+1-919-998-2000, invest@quintiles.com

Weitere Storys: Quintiles Transnational Corp.
Weitere Storys: Quintiles Transnational Corp.
  • 20.03.2006 – 22:24

    Quintiles Data Management to Conduct 200th EDC Trial

    Research Triangle Park, North Carolina (ots/PRNewswire) - - Emerging U.S. company Aerovance Inc. studying COPD drug in U.K. Quintiles Transnational Corp. today announced that it has reached a significant milestone in data management -- the 200th clinical trial using Electronic Data Capture (EDC). Quintiles is using EDC in a trial being conducted in the United Kingdom for Aerovance, Inc., of Berkeley, ...

  • 01.12.2005 – 21:40

    Quintiles Extends Asia Operations With Opening of Vietnam Office

    Research Triangle Park, North Carolina (ots/PRNewswire) - - Now has clinical development offices in eight Asia countries Quintiles Transnational Corp. today announced the extension of its Asia operations with the opening of an office in Hanoi, Vietnam. "Vietnam is an increasingly important market in the region, with its population of 80 million, a strong educational system and a robust healthcare industry," ...

  • 02.06.2005 – 22:05

    Quintiles Laboratories Asia Enhances Services in China

    Research Triangle Park, North Carolina (ots/PRNewswire) - Quintiles Transnational Corp. today announced that Quintiles Laboratories Asia (QLAB Asia) has amended its existing agreement with Peking Union Medical College Hospital (PUMCH) to enhance central laboratory services in China. The new amended agreement with PUMCH enhances services for customers by allowing Quintiles central laboratory (QLAB) facilities in ...